Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$1.65 - $2.92 $372,735 - $659,628
-225,900 Reduced 74.09%
79,000 $139,000
Q1 2024

May 07, 2024

BUY
$1.87 - $2.78 $570,163 - $847,621
304,900 New
304,900 $826,000
Q3 2022

Nov 14, 2022

SELL
$1.1 - $2.06 $10,890 - $20,394
-9,900 Reduced 39.92%
14,900 $16,000
Q2 2022

Aug 15, 2022

SELL
$1.6 - $3.99 $6,560 - $16,359
-4,100 Reduced 14.19%
24,800 $40,000
Q1 2022

May 16, 2022

SELL
$2.8 - $3.96 $134,400 - $190,080
-48,000 Reduced 62.42%
28,900 $104,000
Q4 2021

Feb 14, 2022

SELL
$3.63 - $6.13 $106,722 - $180,222
-29,400 Reduced 27.66%
76,900 $301,000
Q3 2021

Nov 15, 2021

SELL
$5.5 - $7.41 $156,200 - $210,444
-28,400 Reduced 21.08%
106,300 $701,000
Q2 2021

Aug 11, 2021

SELL
$4.35 - $6.35 $261,869 - $382,270
-60,200 Reduced 30.89%
134,700 $830,000
Q1 2021

May 17, 2021

BUY
$3.94 - $7.09 $4,334 - $7,799
1,100 Added 0.57%
194,900 $881,000
Q4 2020

Feb 16, 2021

SELL
$5.45 - $8.65 $553,175 - $877,975
-101,500 Reduced 34.37%
193,800 $1.16 Million
Q3 2020

Nov 16, 2020

BUY
$4.34 - $11.43 $1.12 Million - $2.94 Million
257,400 Added 679.16%
295,300 $2.19 Million
Q2 2020

Aug 14, 2020

BUY
$1.85 - $5.29 $31,820 - $90,988
17,200 Added 83.09%
37,900 $152,000
Q1 2019

May 15, 2019

BUY
$8.47 - $14.36 $42,350 - $71,800
5,000 Added 31.85%
20,700 $275,000
Q4 2018

Feb 14, 2019

SELL
$7.18 - $8.83 $84,006 - $103,311
-11,700 Reduced 42.7%
15,700 $135,000
Q3 2018

Nov 14, 2018

BUY
$5.92 - $8.35 $60,976 - $86,005
10,300 Added 60.23%
27,400 $205,000
Q1 2018

May 15, 2018

SELL
$5.75 - $7.97 $55,775 - $77,309
-9,700 Reduced 36.19%
17,100 $100,000
Q4 2017

Feb 14, 2018

BUY
$4.46 - $6.45 $119,528 - $172,860
26,800
26,800 $158,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.